Family Practice News Digital NetworkHeart of a Lion: Rheumatologist Holds Fast to His Charitable PlansFamily Practice News Digital NetworkDr. Lee's undertaking is inspired by his beloved aunt, Maureen Rayner, of Bournemouth in the south of England,…
ecancermedicalscienceIntensified Immunochemotherapy Benefits B-Cell LymphomaDoctors LoungeFor patients with untreated diffuse large B-cell lymphoma, intensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and…
ecancermedicalscienceIntense Chemo Best for Aggressive LymphomaMedscapeNovember 29, 2011 — Adding rituximab to a dose-intensive immunochemotherapy regimen significantly improves survival in young patients with diffuse large B cell lymphoma with low-i…
US Oncology Research Affiliated Investigators Participated in Studies that …MarketWatch (press release)"When we presented our data with the Syk inhibitor fostamatinib at the ASH plenary session in 2008, B Cell Receptor signaling inhibitors were …
Talon Therapeutics Announces First Patient Enrolled in the Phase 3 OPTIMAL>60 …MarketWatch (press release)The title of the DSHNHL study is "Improvement of outcome and reduction in toxicity in elderly patients with CD20+ aggressive B-cell lymp…
Intensive chemotherapy aids survivalInsideireland.ieAn intensive course of the medical treatment alongside prescription drug rituximab can double remission time for a younger patient with large B-cell lymphoma. Scientists from French study group Groupe…
Cancer Research UKIntensified Chemo Boosts Survival in B-Cell LymphomaMedPage TodayThe three-year overall survival rate with intensive chemotherapy plus rituximab was 92%, compared with 84% among patients receiving a more conventional chemotherapy regi…
Intensified regimen effective in large B-cell lymphomaOncology UpdateIntensified immunochemotherapy with rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin and prednisone (R-ACVBP) significantly improves survival in patients with low- to in…
Cancer Research UKAggressive Lymphoma – Intensive Chemotherapy Significantly Improves Survival …Medical News TodayAccording to a study published Online First in The Lancet, younger individuals who suffer with diffuse large B-cell lymphoma who receive…
FDA clears Spectrum to remove bioscan for Zevalin treatmentPharmaceutical Business ReviewSpectrum said with the approval of removing bioscan, patients undergoing treatment with Zevalin will now receive two infusions of rituximab, followed by a 10-minut…